Letermovir should be first-line cytomegalovirus prophylaxis in lung transplant recipients
Alyssa Mezochow, E. Clausen, Kathryn S. Whitaker, Tamara Claridge, Emily A. Blumberg, Andrew Courtwright
Topics & Concepts
MedicineCytomegalovirusIntensive care medicineCytomegalovirus infectionLungImmunologyInternal medicineHuman immunodeficiency virus (HIV)Human cytomegalovirusViral diseaseHerpesviridaeVirusCytomegalovirus and herpesvirus researchHerpesvirus Infections and TreatmentsTransplantation: Methods and Outcomes